Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Just My Opinion who wrote (990)	6/7/1998 1:42:00 AM
From: Stephen How	Read Replies (1) of 1432

Biotime 10K typo? In the recent 10K, in the Competition section, Pentaspan&reg's use in leukapheresis is described: Other blood plasma replacement products are being developed, and clinical trials have either begun or are expected to begin in the near future for some of these products, including Pentaspan (a solution used for the collection of red blood cells from patients) and a genetically engineered human albumin. I think they meant to say "collection of white blood cells" (leukapheresis). Extremely small point, it's prolly just a typo. They should fix it in the next 10K. Steve btim.dyn.ml.org (new server!)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next